Intercept Pharmaceuticals proposes follow-on

Intercept Pharmaceuticals Inc. (NASDAQ:ICPT), New York, N.Y. Business: Hepatic, Endocrine/Metabolic Date announced: 6/10/13 Type: Follow-on To be raised: Up to $63.3 million Shares: 1.7 million Price ...